ImmunityBio (IBRX) stock slips after SEC filing tweaks $505 million insider note — what traders watch next
ImmunityBio shares slipped 1.6% to $6.35 in late-morning trading Monday following news of an amendment to a sizable convertible note held by an affiliate of its executive chairman. The stock fluctuated between $6.28 and $6.92, with roughly 16.8 million shares changing hands.